IVERIC bio (ISEE) Misses Q2 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ISEE Hot Sheet
Join SI Premium – FREE
IVERIC bio (NASDAQ: ISEE) reported Q2 EPS of ($0.41), $0.11 worse than the analyst estimate of ($0.30).
As of June 30, 2022, the Company had $312 million in cash, cash equivalents and available for sale securities.
For earnings history and earnings-related data on IVERIC bio (ISEE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Superconductor (AMSC) Misses Q2 EPS by 2c ; Offers Guidance
- Acadia Pharma (ACAD) Tops Q3 EPS by 11c, Beats on Revenue; Offers FY26 Revenue Guidance
- ZoomInfo Technologies Inc. (GTM) Reports In-Line Q3 EPS; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
